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Retrospective evaluation of laboratory-confirmed and
recovered cases of influenza A(H1N1)v
Funda SEVENCAN1, Mehmet Melikşah ERTEM2, Neval ÖZÇULLU1, Vedat DORMAN1,
Abdulvahit ORMANLI1, Namık Kemal KUBAT1, Nurhan ALBAYRAK3, Ayşe Başak ALTAŞ3

Aim: To retrospectively evaluate patients that were diagnosed with H1N1 and recovered from the disease in the initial
period of an influenza A(H1N1)v epidemic in the province of Diyarbakir. It is estimated that 34-67 million individuals
around the world have been infected by influenza A(H1N1)v, that 154,000-303,000 individuals have been hospitalized,
and that 7000-13,000 individuals have lost their lives.
Materials and methods: We were able to include 250 of 362 cases (69.0%) of confirmed influenza A(H1N1)v, from
which the patients recovered, from the samples received between 19 October and 3 December 2009 after a pandemic
alarm was given in the province of Diyarbakır. Patients with laboratory-confirmed cases were reached by telephone 15
days after the onset of influenza symptoms.
Results: In terms of demographics, 44.8% of patients were between the ages of 0-14, 51.6% were male, and 44.0% were
students. In 77.6% of the cases, fever was observed, while 53.2% had coughs and 18.4% had vomiting problems. It
was determined that patients older than 45 years old, pregnant women, and individuals with chronic diseases were
hospitalized more frequently than the young, nonpregnant women, and individuals without a chronic disease. The
secondary attack rate within the clinic was 24.6%.
Conclusion: Children and individuals with chronic diseases are important risk groups. It is believed that precautions
such as hand-washing, limiting visits, and ensuring proper ventilation within houses will reduce in-house infectivity
and the secondary attack rate.
Key words: Influenza (H1N1)v, retrospective study, Diyarbakır

Laboratuvar olarak doğrulanmış ve iyileşmiş influenza a(H1N1)v vakalarının
retrospektif değerlendirilmesi
Amaç: Dünyada 34-67 milyon kişinin influenza A(H1N1)v ile enfekte olduğu, 154-303 bin kişinin bu nedenle hastaneye
yattığı, 7-13 bin kişinin ise öldüğü tahmin edilmektedir. Beş yaş altı çocukların, gebelerin ve astım, kalp hastalığı gibi
herhangi bir kronik hastalığı olanların influenza A(H1N1)v gribi açısından risk altında oldukları belirtilmektedir. Bu
araştırmada, Diyarbakır İli’ndeki influenza A(H1N1)v salgınının ilk dönemlerinde H1N1 pozitifliği doğrulanmış ve
iyileşmiş vakaların retrospektif olarak değerlendirilmesi amaçlanmıştır.
Yöntem ve gereç: Diyarbakır İli’nde pandemi alarmı verildikten sonraki 19 Ekim-3 Aralık 2009 tarihleri arasında
alınan numunelerden influenza A(H1N1)v doğrulanmış ve iyileşmiş olan 362 vakanın 250’si (% 69,0) araştırmaya dahil
edilebilmiştir. Doğrulanmış vakalara semptomlarının başlangıcından 15 gün sonra telefon aracılığı ile ulaşılmıştır.
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Bulgular: Vakaların % 44,8’i 0-14 yaş grubunda, % 51,6’sı erkek, % 44,0’ı ise öğrencidir. Vakaların % 77,6’sında ateş,
% 53,2’sinde öksürük, % 18,4’ünde kusma görülmüştür. 45 yaş ve üstü vakaların diğer yaş gruplarına, gebe olanların
olmayanlara, kronik hastalığı olanların olmayanlara göre daha fazla hastaneye yattıkları saptanmıştır. Vakaların klinik
hane içi sekonder atak hızı % 24,6’dır.
Sonuç: Çocuklar ve kronik hastalığı olanlar influenza A(H1N1)v açısından önemli risk gruplarıdır. Hane içinde el
yıkama, ziyaretlerin kısıtlanması ve havalandırma gibi önlemlerin, hane içi bulaştırıcılığı ve sekonder atak hızını
azaltacağı düşünülmektedir.
Anahtar sözcükler: İnfluenza (H1N1)v, retrospektif çalışma, Diyarbakır

Introduction
Influenza A viruses are negative-stranded
RNA viruses of the family Orthomyxoviridae (1).
Influenza A(H1N1)v is a triple-reassortant influenza
virus, containing genes from human, swine, and
avian influenza A viruses (2-4). The new influenza A
(H1N1)v was first defined by the CDC in April 2009;
it was reported then that 60.0% of the population
of one Mexican town was infected in the month of
March and that 2 residents of the town died as a
result (5). The CDC declared the influenza A(H1N1)
v epidemic a public health emergency in April of
2009 (6), whereas the WHO declared it pandemic in
June of 2009 (7-10).
Influenza A(H1N1)v spread in North American
within weeks and began to be detected in different
parts of the world. It is estimated that 34-67 million
individuals around the world have been infected
by influenza A(H1N1)v, that 154,000-303,000
individuals have been hospitalized, and that 700013,000 individuals have lost their lives (11).
It is known that the first group to be infected
by influenza A(H1N1)v was travelling adults and
that the fast transition of the virus among humans
by means of adults caused the pandemic (12,13).
The infectivity rate in Mexico was reported to be
1.0%-2.0%, while the mortality rate was reported as
0.2%-0.6% (14,15). Influenza A(H1N1)v has affected
80.0% of individuals under 25 (16). Children under
the age of 5, pregnant women, and individuals with
chronic diseases such as asthma and cardiac diseases
are particularly at risk for influenza A(H1N1)v (5,1719).
In a person that has contact with the virus, clinical
symptoms and findings are observed approximately 2
days (ranging from 1 to 4 days) later. The symptoms of
648

influenza A(H1N1)v are fever, sore throat, nasal flow,
widespread body ache, headache, cold, and weakness,
which are seen in approximately the third day of the
infection (1). It was also stated that diarrhea and
vomiting are seen in 25.0% of cases (5,12).
The clinical attack rate of influenza A(H1N1)v
was calculated as lower than 20.0%. While this value
is higher than the attack rate of seasonal influenza,
it is lower than those of previous pandemics. The
reasons for this are partial immunity in the elderly,
the asymptomatic and/or light course of the disease,
and the variety in the definitions of cases reported by
different countries (8). In the H1N1 case management
scheme prepared by the Ministry of Health of the
Republic of Turkey, a possible case is defined as
the “presence of at least one of the symptoms of
widespread body ache, sore throat, headache, nose
flow, cough, or respiration difficulty with fever or
fever history exceeding 38 °C (armpit) that cannot
be explained with any other reason.” Confirmed
cases of influenza A(H1N1)v are defined as follows: a
“possible case in which pandemic influenza A(H1N1)
v is detected in one of the reference laboratories
determined by the Ministry of Health with real-time
PCR or virus culture” (20).
The aim of this study was to retrospectively
evaluate the cases in which H1N1 positivity was
confirmed and from which patients recovered in the
first stage of an influenza A(H1N1)v epidemic in
Diyarbakır.
Materials and methods
Pandemic influenza (H1N1) was observed for
the first time in the samples taken in the month of
September in Diyarbakır. The intensity of control
efforts against pandemic influenza in the province
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increased from that date onward. After an obvious
increase was detected in H1N1 cases in the province
of Diyarbakır, this study was established, comprising
362 cases of confirmed influenza A(H1N1)v, for
which the patients applied to health centers between
19 October and 3 December 2009 and from which
the patients later recovered. In this definitive-type
study, the researchers tried to reach all patients via
telephone.
The cases were evaluated according to age,
gender, patients’ complaints at the time of applying
to the health centers, recovery period, working status,
pregnancy, presence of chronic disease, hospitalization
and duration of hospitalization, status of travelling,
size of household, and number of persons with similar
complaints within the same house.
It was planned to reach the laboratory-confirmed
patients by telephone 15 days after the onset of
influenza symptoms. Telephone numbers of 52 of the
362 patients (14.4%) could not be found, 60 patients
(16.6%) whose telephone numbers were known were
called 2 times a day but did not answer, and thus 250
cases (69.0%) could be included in the study.
Analyses were carried out with SPSS version 15.0.
In the analyses, percentage distributions, chi-square
tests, Fisher’s exact tests, one-way ANOVA, t-tests,
and 95% confidence interval odds ratios (OR) were
used. A P-value of <0.05 was considered statistically
significant.

It was determined that the healing process of
males and individuals without a chronic disease was
faster than those of females and those with a chronic
disease (2.2 days, from a range of 1.1-4.6 days,
compared to 2.9 days, from a range of 1.4-5.7 days)
(Table 3).
Patients older than 45 were 6.5 times more likely
to be hospitalized than those in the 0-14 age group,
pregnant women were 8.7 times more likely to be
hospitalized than nonpregnant women, those with
chronic diseases were 4.4 times more likely to be
hospitalized than those without such a disease, those
with a lung disease were 3.3 times more likely to be
hospitalized than those without such a disease, and
overweight individuals were 6.9 times more likely to
be hospitalized than those who were not overweight
(Table 4).
The average recovery period for females and those
with a chronic disease was longer compared to those
of males and those without a chronic disease; this
difference was found to be statistically significant
(Table 5).
The number of individuals living in the same
house as the studied influenza patients was found,
as was the number of individuals with similar
complaints. The clinical in-house secondary attack
rate was calculated as 24.6%.
Discussion

Results
For this retrospective study of confirmed cases of
influenza A(H1N1)v from which patients recovered,
some of the characteristics of the 250 cases are
presented in Table 1.
Of the 250 participants, 43.9% were in the 0-14
age group (median age = 16), 51.6% were male, and
30.4% had a chronic disease. It was determined that
23.6% of the confirmed influenza A(H1N1)v cases
required hospitalization, while 3.6% of patients stated
that they had travelled recently (Table 1).
When patient complaints were evaluated, the
following common complaints were found: fever in
77.6% of cases, cough in 53.2%, weakness in 33.2%,
vomiting in 18.4%, and diarrhea in 9.2% (Table 2).

In this study, it was seen that the majority of
patients were from the 0-14 age group (44.8%); the
median age was 16. In a study from the United States,
it was demonstrated that 60.0% of patients from 642
confirmed cases were 18 years old or younger (16).
Similarly, in a retrospective study conducted by
Echevarria-Zuno et al., the median age of confirmed
patients was 16 (14). In a study conducted by CastroJimenez et al. on 183 confirmed cases, the majority
of patients were young (21). One of the influenza
A(H1N1)v risk groups comprises children and the
young.
It was determined in the present study that
in 44.0% of the confirmed 250 cases, the patients
were students, the largest demographic category in
649
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Table 1. The distribution of some characteristics of confirmed cases of influenza
A(H1N1)v (October-December 2009, Diyarbakır).
n
Age (n = 250)
0-14
15-24
25-44
≥45
Mean ± sd = 18.0 ± 12.0

112
65
63
10
Median = 16.0

%
44.8
26.0
25.2
4.0
Min-max = 1-54

Sex (n = 250)
Male
Female

129
121

51.6
48.4

Employment (n = 250)
Student
Housewife
Teacher
Health staff
Other*

110
36
11
4
89

44.0
14.4
4.4
1.6
35.6

Pregnancy** (n = 77)
Yes
No

18
59

23.4
76.6

Chronic Diseases (n = 250)
No
Yes
Chronic pulmonary diseases
Chronic nephropathy
Overweight
Chronic cardiac diseases
Hypertension
Diabetes mellitus
Immunodeficiency
Other***

174
76
21
10
6
6
4
3
2
28

69.6
30.4
27.6
13.2
7.8
7.8
5.2
3.9
2.6
36.8

Hospital stay (n = 250)
No
Yes
Intensive care unit
Mechanical ventilation

191
59
13
-

76.4
23.6
22.0
-

52
130
67
Median = 5.0

20.9
52.2
26.9
Min-max = 1-22

241
9

96.4
3.6

52
85
112
Median = 5.0

20.9
34.1
45.0
Min-max = 1-22

Duration of hospital stay (n = 249)
≤3
4-6
≥7
Mean ± sd = 5.5 ± 2.6
Travelling (n = 250)
No
Yes
Size of household (n = 249)
≤3
4-5
≥6
Mean ± sd = 5.5 ± 2.6

* Jobless, <7 years;
**Women 15-49 years old;
***Chronic gastrointestinal diseases, cancer, infectious diseases, rheumatic diseases
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Table 2. The distribution of complaints for confirmed influenza A(H1N1)v cases
(October-December 2009, Diyarbakır).
Symptoms

n

%

Fewer

194

77.6

Cough

133

53.2

Exhaustion

83

33.2

Headache

62

24.8

Sore throat

51

20.4

Vomiting

46

18.4

Nausea

44

17.6

Nasal flow

44

17.6

Diarrhea

23

9.2

Common muscle aches

20

8.0

Dyspnea

19

7.6

Abdominal pain

14

5.6

terms of employment status. In the retrospective
study conducted by Echevarria-Zuno et al., females,
children, and the 10-19 age group were found to be at
risk of influenza A(H1N1)v infection, while babies,
individuals older than 60, and individuals with
chronic diseases were found to be at risk of serious
diseases (14). Since students are both children and
present in communal places, they are very important
in terms of in-school spreading of infection (22).

hand, it was found that the most frequent underlying
chronic disease in both adults and children was
asthma (24). Individuals with chronic diseases are
important risk groups for influenza A(H1N1)v.

No difference was seen in respect to the occurrence
rate between the genders, while it was determined
that the recovery period of females was longer than
that of males. In the study by Echevarria-Zuno et al.,
it was proved that the occurrence rate and seriousness
of the disease were not related to gender (14). It was
found that those without a chronic disease recovered
faster compared to those with chronic diseases. The
higher percentage of females with a chronic disease
compared to males might be a reason for the longer
recovery periods of females.

The most frequently cited symptoms were,
respectively, fever, cough, weakness, and headache.
In the retrospective evaluation of confirmed cases by
Echevarria-Zuno et al., similarly, the most frequently
cited symptoms were fever, cough, and headache
(14). In other studies, it was reported that the most
frequently cited symptoms were, respectively,
fever, cough, and sore throat (16,21). Vomiting
was observed in 18.4% of cases while diarrhea was
observed in 9.2%. In a study conducted by the Novel
Swine-Origin Influenza A (H1N1) Virus Investigation
Team, diarrhea and vomiting were observed in onefourth of the cases, different from other studies (16).
Although there is a difference among countries in
respect to clinical symptom percentages, the order of
occurrence frequency is similar.

It was found that 30.4% of confirmed cases in
this study also exhibited a chronic disease, and that
the most frequently cited chronic disease was lung
disease (27.6%). In a study conducted by Mangtani et
al., chronic diseases such as asthma, diabetes mellitus,
morbid obesity, and diseases affecting the immune
system were present in more than 70.0% of the cases
(23). In a study conducted by Jain et al., on the other

It was determined that 23.6% of confirmed
cases were hospitalized. In the study conducted by
the Novel Swine-Origin Influenza A (H1N1) Virus
Investigation Team, the hospitalization rate for 642
cases was reported as 9.0% (16), while in the study
by Castro-Jimenez et al., the rate of hospitalization
for 183 cases was reported as 14.2% (21). Moreover,
it was determined that the hospitalization rates for
651
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Table 3. Distribution of recovery time for confirmed influenza A(H1N1)v cases in accordance
with age, sex, pregnancy, and chronic diseases (October-December 2009, Diyarbakır).
Recovery Time
≤7 days

>7 days

P

OR (95% CI)

0.085

ref

n

%

n

%

0-14

97

89.8

11

10.2

15-24

50

80.6

12

19.4

2.1 (0.8-5.6)

25-44

47

77.0

14

23.0

2.6 (1.0-6.8)

≥45

7

70.3

3

30.0

3.8 (0.7-20.1)

Age

Sex
Male

110

88.7

14

11.3

Female

91

77.8

26

22.2

No

47

81.0

11

19.0

Yes

10

58.8

7

41.2

No

149

88.2

20

11.8

Yes

52

72.2

20

27.8

No

198

83.5

39

16.5

Yes

3

75.0

1

25.0

No

201

84.5

37

15.5

Yes

-

-

3

100.0

No

197

83.5

39

16.5

Yes

4

80.0

1

20.0

No

189

84.4

35

15.6

Yes

12

70.6

5

29.4

No

197

84.0

37

16.0

Yes

7

70.0

3

30.0

No

198

84.3

37

15.7

Yes

3

50.0

3

50.0

0.023

ref
2.2 (1.1-4.6)

Pregnancy**
0.103

ref
2.9 (0.9-9.6)

Any other chronic diseases
0.002

ref
2.9 (1.4-5.7)

Hypertension
0.519*

ref
1.7 (0.2-16.7)

Diabetes mellitus
0.004*

-

1.000*

ref

Chronic cardiac disease
1.3 (0.1-11.6)

Chronic pulmonary disease
0.171*

ref
2.3 (0.7-6.8)

Chronic nephropathy
0.220*

ref
2.2 (0.6-9.1)

Overweight

*Fisher’s exact test
**Women 15-49 years old
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0.059*

ref
5.4 (1.0-27.5)
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Table 4. Distribution of hospital stay for confirmed influenza A(H1N1)v cases in accordance with age, sex, pregnancy,
and chronic diseases (October-December 2009, Diyarbakır).
Hospital stay
Yes

No

P

OR (95% CI)

n

%

n

%

0-14

21

18.8

91

81.2

15-24

18

27.7

47

72.3

1.7 (0.8-3.6)

25-44

14

22.2

49

77.8

1.2 (0.5-2.8)

≥45

6

60.0

4

40.0

6.5 (1.4-30.7)

Male

27

20.9

102

79.1

Female

32

26.4

89

73.6

No

11

18.6

48

81.4

Yes

12

66.7

6

33.3

No

26

14.9

148

85.1

Yes

33

43.4

43

56.6

No

57

23.2

189

76.8

Yes

2

50.0

2

50.0

No

56

22.7

191

77.3

Yes

3

100.0

-

-

No

56

23.0

188

77.0

Yes

3

50.0

3

50.0

No

49

21.4

180

78.6

Yes

10

47.6

11

52.4

No

55

22.9

185

77.1

Yes

4

40.0

6

60.0

No

55

22.5

189

77.5

Yes

4

66.7

2

33.3

Age
0.024

ref

Sex
0.305

ref
1.4 (0.7-2.5)

Pregnancy**
<0.005

ref
8.7 (2.7-28.4)

Any other chronic diseases
<0.005

ref
4.4 (2.3-8.5)

Hypertension
0.237*

ref
3.3 (0.5-24.1)

Diabetes mellitus
0.013*

-

Chronic cardiac disease
0.145*

ref
3.3 (0.7-17.1)

Chronic pulmonary disease
0.013*

ref
3.3 (1.3-8.3)

Chronic nephropathy
0.252*

ref
2.2 (0.6-8.2)

Overweight
0.029*

ref
6.9 (1.2-38.5)

*Fisher’s exact test
**Women 15-49 years old
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Table 5. Distribution of recovery time and duration of hospital stay of confirmed influenza A(H1N1)v
cases in accordance with age, sex, pregnancy, and chronic diseases (October-December 2009,
Diyarbakır).
Recovery time (days)
Mean ± sd

Duration of hospital stay (days)
Mean ± sd

0-14

4.90 ± 3.72

6.60 ± 4.44

15-24

5.53 ± 3.20

6.89 ± 7.40

25-44

6.70 ± 5.90

8.71 ± 6.07

≥45

6.00 ± 3.49

9.00 ± 6.42

Age

F = 2.367

P = 0.072

F = 0.514

P = 0.674

Sex
Male

4.71 ± 2.83

7.31 ± 6.30

Female

6.47 ± 5.31

7.56 ± 5.83

t = 3.236

P = 0.001

t = 0.160

P = 0.874

Pregnancy*
Yes

8.06 ± 6.68

7.83 ± 6.26

No

6.34 ± 5.23

7.64 ± 6.04

t = 1.113

P = 0.269

t = 0.077

P = 0.940

Any other chronic diseases
Yes

6.75 ± 5.19

8.67 ± 6.90

No

5.06 ± 3.77

5.84 ± 4.13

t = 2.833

P = 0.005

t = 1.814

P = 0.075

*Women 15-49 years old
One-way ANOVA and t-test

patients older than 45, pregnant women, individuals
with chronic diseases, individuals with lung diseases,
and overweight individuals were higher compared to
other groups. In a study conducted by Jamieson et al.
that included 34 pregnant women between the ages
of 15 and 44, it was estimated that hospitalization
rates of pregnant women were higher compared to
those of normal populations (18). The difference
in the hospitalization rates of confirmed cases
might have been caused by the difference of the
frequency of chronic diseases of cases. It was found
that approximately one-fifth of hospitalized cases
needed intensive care. In a study conducted by Jain
et al., it was stated that 25% of 272 confirmed and
hospitalized cases required intensive care (24). The
654

hospitalization rates of confirmed cases were different
than the data from the literature, whereas the rate of
necessity for intensive care was similar. It would be
useful to evaluate international case managements
and hospitalization indications in order to explain
the differences in hospitalization rates.
Particles contaminated with influenza A(H1N1)v
are spread by means of coughing and sneezing. It is
known that crowded environments are an important
factor in the spread of influenza A(H1N1)v (25). In
this study, the median number of individuals in a
household was 5.0, whereas in-house infectivity was
24.6%. In a report published by Yang et al., the best
determiner of infectivity was the secondary attack
rate; this rate for influenza A(H1N1)v was 27.3%
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(26). In that study, it was found that housewives
were the second group in which influenza A(H1N1)
v was seen most frequently. This might be due to
the fact that children are in contact with housewives
most regularly within the house, and housewives are
present in the same environment for a very long time.
It is believed that measures such as hand-washing,
limiting visits, and ensuring proper ventilation
within the house (5) will reduce in-house infectivity
and the secondary attack rate.
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